MS
Morgan Stanley disclosed a 5.2% stake in IMUX
Morgan Stanley reported owning 5.2% of Immunic, Inc. (IMUX) (704,244 shares) in a Schedule 13G filed Nov 13, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
Cookies show us what works. Privacy
Cookies show us what works. Privacy
Morgan Stanley reported owning 5.2% of Immunic, Inc. (IMUX) (704,244 shares) in a Schedule 13G filed Nov 13, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.